A coronary heart disease risk model for predicting the effect of potent antiretroviral therapy in HIV-1 infected men
Research output: Contribution to journal › Journal article › Research › peer-review
Many HIV-infected patients on highly active antiretroviral therapy (HAART) experience metabolic complications including dyslipidaemia and insulin resistance, which may increase their coronary heart disease (CHD) risk. We developed a prognostic model for CHD tailored to the changes in risk factors observed in patients starting HAART.
| Original language | English |
|---|---|
| Journal | International Journal of Epidemiology |
| Volume | 36 |
| Issue number | 6 |
| Pages (from-to) | 1309-1318 |
| Number of pages | 10 |
| ISSN | 0300-5771 |
| DOIs | |
| Publication status | Published - 2007 |
- Adult, Aged, Anti-Retroviral Agents, Antiretroviral Therapy, Highly Active, Coronary Disease, Follow-Up Studies, Great Britain, HIV Infections, HIV-1, Humans, Male, Middle Aged, Prognosis, Proportional Hazards Models, Risk Assessment, Risk Factors
Research areas
ID: 4039421